Grimes & Company »

Heron Therapeutics shares owned by Grimes & Company

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Grimes & Company from 13F filings

Historical chart of Grimes & Company investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Grimes & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Grimes & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $130k 47k 2.77
2023-12-31 $81k 48k 1.70
2023-09-30 $50k 49k 1.03
2023-06-30 $56k 48k 1.16
2023-03-31 $57k 38k 1.51
2022-12-31 $39k 16k 2.50
2022-09-30 $67k 16k 4.25
2022-06-30 $43k 16k 2.77
2022-03-31 $86k 15k 5.70
2021-12-31 $105k 12k 9.11
2021-09-30 $141k 13k 10.72
2021-06-30 $185k 12k 15.56